DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Programme Preview
    • The DDL Incubator
    • Attending Exhibitors and Sponsors
    • Exhibition & Sponsorship Opportunities
    • New Researcher Network
    • Hotel and Travel
    • Call for Papers
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • Annual Aerosol Science Conference
    • RDD 2027
  • The Aerosol Society logo
Isaac Mohar

Isaac Mohar

Gradient

Paper: Overview of the Nonclinical Safety Program for 1,1-Difluoroethane (HFA-152a) as a Low Global Warming Potential Metered Dose Inhaler Propellant

Download Paper

Dr. Mohar is a principal toxicologist at Gradient where he has been a research consultant since 2014. As a research consultant he supports clients in the pharmaceutical, medical device, agrochemical, and consumer products industries. Prior to working at Gradient, Dr. Mohar conducted research in areas of drug-induced liver injury, reproductive genetics, immune tolerance, and viral and parasitic immunity. He received a doctorate in toxicology from University of Washington in 2008 and conducted postdoctoral training at Seattle Biomedical Research Institute and University of Washington. He is an author on 22 peer-reviewed publications and is an active member of the American College of Toxicology and Society of Toxicology.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk